- advertisement -

Intensive control and complications - 30 year study

Discussion in 'Parents of Children with Type 1' started by Darryl, Jul 28, 2009.

  1. Darryl

    Darryl Approved members

    Joined:
    May 8, 2008
    Messages:
    4,313
    Very encouraging article for those who maintain tight BG control published this week in
    the Archives of Internal Medicine. This is the abstract. The full text article is here:
    http://archinte.ama-assn.org/cgi/content/full/169/14/1307?home. I can't publish the
    document here as it is only available for purcase. It contains more graphs, discussion,
    and statistics but the conclusion is fairly clear.

    Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years' Duration

    Arch Intern Med. 2009;169(14):1307-1316.

    Results After 30 years of diabetes, the cumulative incidences of proliferative retinopathy,
    nephropathy, and cardiovascular disease were 50%, 25%, and 14%, respectively, in the
    DCCT conventional treatment group, and 47%, 17%, and 14%, respectively, in the EDC cohort.

    The DCCT intensive therapy group had substantially lower cumulative incidences
    (21%, 9%, and 9%) and fewer than 1% became blind, required kidney replacement,
    or had an amputation because of diabetes during that time.

    Conclusion The frequencies of serious complications in patients with T1DM, especially when
    treated intensively, are lower than that reported historically.
     
  2. frizzyrazzy

    frizzyrazzy Approved members

    Joined:
    Dec 23, 2006
    Messages:
    14,141
  3. WhyMyBabyGirl

    WhyMyBabyGirl Approved members

    Joined:
    Jun 8, 2009
    Messages:
    117
    Thank you for posting that Darryl, I didn't see the other posts.
     
  4. Darryl

    Darryl Approved members

    Joined:
    May 8, 2008
    Messages:
    4,313
  5. buggle

    buggle Approved members

    Joined:
    Mar 24, 2008
    Messages:
    4,267
    I thought this was published a long time ago. Did they update the study with new data or something?
     

Share This Page

- advertisement -

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice